Wacker Biotech GmbH – FDA Inspection, Mar 6, 2019

Record Details

This FDA Inspection record concerns Wacker Biotech GmbH, with an inspection on March 6, 2019, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Wacker Biotech GmbH
Inspection Date: March 6, 2019
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Michael A. Charles (FDA Associated Person)

View Company Profile

ID · e6519bf6-8060-4258-82fe-d7af0103f917

Inspection Facts

Inspection number: 1081634
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Wacker Biotech GmbH

FDA Inspection

Wacker Biotech GmbHMarch 6, 2019

Wacker Biotech GmbH – FDA Inspection, Mar 6, 2019

Record Details

This FDA Inspection record concerns Wacker Biotech GmbH, with an inspection on March 6, 2019, issued by the Office of Inspections and Investigations, covering human drugs.